Urokinase plasminogen activator [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

====== Urokinase plasminogen activator ======
 

[[Urokinase]] [[plasminogen activator]] (uPA) is a protein that plays a crucial role in the fibrinolytic system, which is responsible for breaking down blood clots. It is an enzyme that activates plasminogen, a precursor to plasmin, which is the enzyme responsible for breaking down fibrin, a component of blood clots.

Here's a breakdown of the process:

Activation of Plasminogen: Urokinase plasminogen activator converts plasminogen into plasmin.

Plasmin Activity: Plasmin is a proteolytic enzyme that can break down fibrin, a protein involved in blood clot formation. This fibrinolysis process helps to dissolve blood clots.

Clinical Applications: Urokinase and other thrombolytic agents, such as tissue plasminogen activator (tPA), are sometimes used in medical settings to treat conditions where blood clots are undesirable. For example, they may be used to dissolve clots in certain types of strokes, myocardial infarctions (heart attacks), or deep vein thrombosis.

It's important to note that the use of thrombolytic agents carries potential risks, and their administration is typically carefully monitored in a clinical setting. These agents are often used in emergency situations where the benefits of dissolving a clot quickly outweigh the risks.

Urokinase has been used less frequently in recent years, and tissue plasminogen activator (tPA) is more commonly used for thrombolytic therapy.